본문으로 건너뛰기
← 뒤로

Advanced dual primary male breast cancer and lung cancer: A case report and literature review.

Oncology letters 2026 Vol.31(1) p. 2

Xing X, Li J, Wang Y, Zhang S, Li J, Wang Y, Zhang D, Liao D

📝 환자 설명용 한 줄

The current report presents a unique case of advanced male invasive breast cancer coexisting with synchronous primary lung adenocarcinoma, a rare clinical manifestation.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Xing X, Li J, et al. (2026). Advanced dual primary male breast cancer and lung cancer: A case report and literature review.. Oncology letters, 31(1), 2. https://doi.org/10.3892/ol.2025.15355
MLA Xing X, et al.. "Advanced dual primary male breast cancer and lung cancer: A case report and literature review.." Oncology letters, vol. 31, no. 1, 2026, pp. 2.
PMID 41180847

Abstract

The current report presents a unique case of advanced male invasive breast cancer coexisting with synchronous primary lung adenocarcinoma, a rare clinical manifestation. The case contributes to the limited literature on male breast cancer and its association with multiple primary malignancies. The patient, a 59-year-old man, presented with a large ulcerative mass in the left breast (14×10 cm) and ground-glass opacities with calcified nodules in the right lower lung lobe (14×14 mm). Imaging and pathology confirmed stage IIIB invasive ductal carcinoma of the breast [human epidermal growth factor receptor-2-positive, estrogen receptor-positive (80%) and progesterone receptor-positive (5%)] and minimally invasive lung adenocarcinoma. Treatment consisted of neoadjuvant chemotherapy (epirubicin + carboplatin + trastuzumab + pertuzumab), a modified radical mastectomy with latissimus dorsi flap reconstruction and a thoracoscopic lung wedge resection. The therapeutic approach resulted in partial remission of the breast cancer prior to surgery and a stable disease status in the lung, with no recurrence at the 1-year follow-up. This case underscores the importance of comprehensive, integrative strategies and long-term follow-up for managing rare, complex cancer cases.

같은 제1저자의 인용 많은 논문 (5)